Mirviss Jeffrey B.
- SEC CIK
- 0001566094
No open-market purchases or sales filed in the past year.
Current role at each company
- CNMD CONMED CorpDirectoras of Jul 2, 2026
- BSX Boston Scientific CorpEVP&Pres, Periph Interventas of Feb 25, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mirviss Jeffrey B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BSX Boston Scientific Corp
EVP&Pres, Periph Intervent24 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2025 (view filing) | Feb 24-25 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −7.36K | $104.16 | −$766.9K | −22.2%25.8K after | 2 lots10b5-1 |
| Feb 19, 2025 (view filing) | Feb 19 | Same day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −1.51K | $105.35 | −$159.1K | −4.4%33.1K after | 10b5-1 |
| Feb 13, 2025 (view filing) | Feb 12 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −13.0K | $105.06 | −$1.37M | −31.4%28.5K after | 10b5-1 |
| Jan 3, 2025 (view filing) | Jan 3 | Same day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −7.15K | $89.86 | −$642.7K | −20.1%28.5K after | 10b5-1 |
| May 30, 2024 (view filing) | May 29 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −63.8K | $75.10 | −$4.79M | −69.5%28.0K after | 10b5-1 |
| Mar 19, 2024 (view filing) | Mar 18 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −14.5K | $66.45 | −$963.9K | −20.0%58.1K after | 10b5-1 |
| Feb 22, 2024 (view filing) | Feb 21 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −4.96K | $66.35 | −$329.1K | −6.4%72.6K after | 10b5-1 |
| Jan 10, 2024 (view filing) | Jan 9 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −15.2K | $59.25 | −$898.9K | −21.1%56.6K after | 10b5-1 |
| Jan 5, 2024 (view filing) | Jan 4 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −15.0K | $58.40 | −$876.0K | −21.0%56.6K after | 10b5-1 |
| Jan 4, 2024 (view filing) | Jan 3 | 1 day | Mirviss Jeffrey B.EVP&Pres, Periph Intervent | SSale | −11.9K | $57.82 | −$689.9K | −17.4%56.6K after | 10b5-1 |